Regulatory Affairs Professionals Society

This Week at FDA: Reactions to FDA’s Bayesian methods guidance, GDUFA science report, and more

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation and what we’re reading from around the web. This week, ...
Frontiers

Cardiovascular imaging breakthroughs: From vulnerable plaque characterization to procedural guidance

Cardiovascular imaging represents a cornerstone in the diagnosis and treatment of heart disease, with recent technological advances revolutionizing both ...